Fine Foods’ Brembate Pharma manufacturing site has a new finished product warehouse.

The new structure has a covered surface of 1,350 square meters and consists of a compact automated storage system. Movable shelves on tracks optimize the available space.

The moving parts were designed to obtain the highest levels of safety for the operators and are equipped with modern check systems.

This € 1.75 M investment is the first milestone of the site expansion that will bring FF’s Pharma capacity to approximately 150% of the current combined capacity of the two existing sites.

In support to the continuous amazing growth and to sustain the constantly increasing trust from its customers, Fine Foods has hired 120 new employees from January 2014 through December 2016. Approximately 50% of the new hires was assigned to technical areas, such as R&D labs, Quality Assurance, Quality Control, Engineering, Industrialization, while the other 50% was allocated to the strengthening of operations. The level of education of the new hires is quite high, with 50 High School Diplomas and 29 University Degrees.

The recruitment process was strongly focused on youth employment: 50% of the new hires was under the age of 30.

Fine Foods is one of the sponsors of an independent study commissioned by FSE (Food Supplement Europe) on the benefits deriving from the use of Food Supplements containing Omega-3 EPA + DHA.

The study, carried out by Frost & Sullivan and focused on a population aged 55 and over, shows that a regular use of Food Supplements containing Omega-3 could bring € 12.9 billion savings on healthcare costs in the EU.

The complete study is available upon request, by sending a message to info@finefoods.it with subject “Omega-3 Study”

Download FSE_HCCS Omega3_Summary

Download FSE_HCCS Omega3_Infographic

 

Time is of the essence.

There is an increased demand to shorten the time lapsing between the idea of a new product and the launch. One of the areas of improvement is production scale-up.

With the new Ronchi FA8 Tablet Press, Fine Foods expects a much smoother scale-up of tablet productions, in that the new equipment provides, on a pilot level, information very representative of the production on a large scale.

The investment is the latest move of Fine Foods’ program aimed to equip R&D and QC laboratories with the latest and most performing technologies.